Client login From 24 June 2024, the new name for Across Health is Precision AQ!…. Read more

Key omnichannel trends
in biopharma

32

08 November 2021 : Blog issue N°32 by Fonny Schenck


In 2021, Across Health ran its thirteenth annual Maturometer study to take the pulse of pharma’s efforts and ambitions in the digital & omnichannel space.

Biopharma digital budgets up, but satisfaction remains low

In the first year after C19 hit, it’s no surprise to see that digital marketing budgets are up. Indeed, within 2 years, digital budgets increased by 42% - and within 6 years, they almost doubled. 

But despite these increased budgets, biopharma satisfaction levels have remained low since 2010. Interestingly, though, the number of “neutrals” has steadily increased over time, to reach 77% in 2020. Are these the “hopefuls”, who believe their new digital efforts may pay off one day…but not just now yet? Did they fail to define clear KPIs upfront to assess the business impact of their increased spend? Did they spend it on low-impact channels? Did the strategy execution create issues? … Or maybe it’s a bit of all of the above?

In any case, the increased biopharma focus on digital did get noticed by HCPs. Indeed, in the Q4 2020 Navigator365™ Core EU4/UK HCP wave:

  • 62% of HCPs found digital offerings from pharma important (up from 54% in 2019);
  • HCP satisfaction levels rose to 42% (from 33% in 2019)…but barely budged in Italy & France.

Source: Navigator365™ Core EU4/UK specialists: Q4 2019 (n = 4104) and Q4 2020 (n=2780)

Omnichannel capabilities remain low

Just increasing digital budgets is no guarantee for success. Indeed, the extra resources need to be ”invested” judiciously. For this, one needs to 

  • know (the omnichannel affinities of) your customers; 
  • have a robust process in place for building a robust omnichannel strategy;
  • be able to execute flawlessly;
  • be able to track impact (and course-correct where needed)

The score for every single one of these important success criteria has declined since 2018 (probably because respondents now feel the “pain” much more vs the 2018 “digital honeymoon” period) and none of them reached the 50% agreement level. Focused, large-scale investment in omnichannel capabilities for all customer-facing functions is therefore urgently needed.

Where does biopharma think “the (omnichannel) puck is going?” 

When asked about their future channel priorities, the 2021 Maturometer respondents expect strong growth for “virtual scientific meetings”, “webcasts”, “remote video detailing”, “rep-triggered email”, and “emedical education”, with AI and marketing automation following closely.

As can already be gathered from the future channel focus, most of the increased omnichannel budgets will continue to be invested in HCPs, but payers and patients are expected to be getting a bigger part of these budgets 2 years from now. 

Finally, across the globe, biopharma staff are turning their attention to “omnichannel”, the common denominator in their top 3 priorities: 1) developing a well-defined customer journey across multiple touchpoints, 2) transforming the field force and 3) experimenting with the mix. Interestingly, customer centricity is much lower down the list, while it is a key enabler for omnichannel success.

In summary, we are arguably at the start of an exciting new era in life sciences, with a strong acceleration and scaling of omnichannel – AND omnistakeholder - engagement. The time to act is now!

 

Further reading: 

 

 


Want to receive the Across Health newsletter?


Or follow us on  LinkedIn

+

Share this article

Use your preferred feature.


Or share this page with a colleague.

+

Healthcare Innovation Tour 2020

To register your interest in joining the tour, and to comply with GDPR so we may send you future emails, please fill out the following information and complete the consent section at the bottom.

+

+

Book an exploratory call

Submit your details via this short form and you will be invited by one of our experts for a free 30-minute call to explore how Navigator365TM can provide an answer to your ambitions, needs and challenges.

+
+

Submit your details

In order to process your contact request and answer your query it is necessary we process your personal data. You can find out more about how we process your personal data and about your rights connected to such processing from our Privacy Policy.

+

Across Health is evolving...

From 24 June 2024, the new name for Across Health is Precision AQ! This change is happening in-line with the rebranding being undertaken by the entire Precision Value & Health team (of which we have been a part since February 2021).

Having joined forces with over 1,200 life-science experts, advisors and creatives across 100+ diverse fields, we will continue to partner with our clients to deliver evidence-based omnichannel engagement strategies while empowering access to life-changing medicines for all.

While we transition across to our new website, click here to see how we are already focusing on HCP engagement in the digital age, fuelled by powerful insights from our Navigator365TM research.

To find out more about our wider global services and unified mission, read our publication here.

+